Most cited papers from Evolva (Switzerland)

Evolva (Switzerland)

What are the most cited papers from Evolva (Switzerland)?

The most cited paper from Evolva (Switzerland) is "Engineering prokaryotic transcriptional activators as metabolite biosensors in yeast" (Mette L. Skjoedt, Tim Snoek, Kanchana Rueksomtawin Kildegaard et al., 2016), with 253 citations. Next come "Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties" (123) and "Oxidation and cyclization of casbene in the biosynthesis of Euphorbia factors from mature seeds of Euphorbia lathyris L." (99).

Published TypeFieldAccess

Showing 37 of 37 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Engineering prokaryotic transcriptional activators as metabolite biosensors in yeast Mette L. Skjoedt, Tim Snoek, Kanchana Rueksomtawin Kildegaard et al. · Nature Chemical Biology	19 Sep 2016	253
2	Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties Michael Eichenberger, Beata Joanna Lehka, Christophe Folly et al. · Metabolic Engineering Open access	31 Oct 2016	123
3	Oxidation and cyclization of casbene in the biosynthesis of Euphorbia factors from mature seeds of Euphorbia lathyris L. Dan Luo, Roberta Callari, Britta Hamberger et al. · Proceedings of the National Academy of Sciences Open access	9 Aug 2016	99
4	Yeast artificial chromosomes employed for random assembly of biosynthetic pathways and production of diverse compounds in Saccharomyces cerevisiae Michael Næsby et al. · Microbial Cell Factories Open access	13 Aug 2009	78
5	Discovery and Reconstitution of the Cycloclavine Biosynthetic Pathway—Enzymatic Formation of a Cyclopropyl Group Dorota Jakubczyk, Lorenzo Caputi, Anaëlle Hatsch et al. · Angewandte Chemie International Edition Open access	25 Feb 2015	75
6	De novo biosynthesis of anthocyanins in Saccharomyces cerevisiae Michael Eichenberger, Anders Hansson, David Fischer et al. · FEMS Yeast Research Open access	16 Apr 2018	74
7	Reconstruction of the biosynthetic pathway for the core fungal polyketide scaffold rubrofusarin in Saccharomyces cerevisiae Peter Rugbjerg, Michael Næsby, Uffe Hasbro Mortensen et al. · Microbial Cell Factories Open access	4 Apr 2013	64
8	Yeast Synthetic Biology Platform Generates Novel Chemical Structures as Scaffolds for Drug Discovery Jens Uwe Klein, Jonathan R. Heal, William D. O. Hamilton et al. · ACS Synthetic Biology Open access	16 Jan 2014	60
9	Improving heterologous production of phenylpropanoids in Saccharomyces cerevisiae by tackling an unwanted side reaction of Tsc13, an endogenous double bond reductase. Beata Joanna Lehka, Michael Eichenberger, Walden Emil Bjørn-Yoshimoto et al. · FEMS Yeast Research Open access	9 Jan 2017	50
10	The important ergot alkaloid intermediate chanoclavine-I produced in the yeast Saccharomyces cerevisiae by the combined action of EasC and EasE from Aspergillus japonicus Curt A. F. Nielsen, Christophe Folly, Anaëlle Hatsch et al. · Microbial Cell Factories Open access	11 Aug 2014	50
11	Indirect and direct routes to C-glycosylated flavones in Saccharomyces cerevisiae Katherina García Vanegas, Arésu Bondrup Larsen, Michael Eichenberger et al. · Microbial Cell Factories Open access	9 Jul 2018	49
12	Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials Saúl Alonso · Journal of Controlled Release Open access	24 Aug 2018	45
13	RNA-seq, de novo transcriptome assembly and flavonoid gene analysis in 13 wild and cultivated berry fruit species with high content of phenolics Vera Thole et al. · BMC Genomics Open access	Dec 2019	44
14	Controlled nail delivery of a novel lipophilic antifungal agent using various modern drug carrier systems as well as in vitro and ex vivo model systems Sandy Naumann, Jean‐Philippe Meyer, Andreas Kiesow et al. · Journal of Controlled Release	18 Feb 2014	44
15	Identification and Microbial Production of the Raspberry Phenol Salidroside that Is Active against Huntington’s Disease Nicolai Kallscheuer et al. · PLANT PHYSIOLOGY Open access	5 Nov 2018	40
16	Dynamic Control of ERG20 and ERG9 Expression for Improved Casbene Production in Saccharomyces cerevisiae Roberta Callari, Yvan Meier, Davide Ravasio et al. · Frontiers in Bioengineering and Biotechnology Open access	Nov 2018	28
17	Production of (S)-2-aminobutyric acid and (S)-2-aminobutanol in Saccharomyces cerevisiae Nora Weber, Anaëlle Hatsch, Ludivine Labagnere et al. · Microbial Cell Factories Open access	23 Mar 2017	28
18	Effect of Pharmaceutical Interventions Targeting Thromboxane Receptors and Thromboxane Synthase in Cardiovascular and Renal Diseases Kjell S. Sakaríassen, Pēteris Alberts, Pierre Fontana et al. · Future Cardiology	28 Aug 2009	26
19	Heavy isotope labeling and mass spectrometry reveal unexpected remodeling of bacterial cell wall expansion in response to drugs Heiner Atze, Yucheng Liang, Jean‐Emmanuel Hugonnet et al. · eLife Open access	9 Jun 2022	25
20	On-chip microfluidic systems for determination of L-glutamate based on enzymatic recycling of substrate Wanida Laiwattanapaisal, Julia N. Yakovleva, Martin Bengtsson et al. · Biomicrofluidics Open access	Mar 2009	22
21	BacHBerry: BACterial Hosts for production of Bioactive phenolics from bERRY fruits Alexey Dudnik et al. · Phytochemistry Reviews Open access	8 Sep 2017	20
22	Production of Putative Diterpene Carboxylic Acid Intermediates of Triptolide in Yeast Victor Forman, Roberta Callari, Christophe Folly et al. · Molecules Open access	13 Jun 2017	18
23	Improvement of whole-cell transamination with Saccharomyces cerevisiae using metabolic engineering and cell pre-adaptation Nora Weber, Marie F. Gorwa‐Grauslund, Magnus Carlquist · Microbial Cell Factories Open access	3 Jan 2017	18
24	The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV‐077 is a more potent inhibitor of platelet function than aspirin Pierre Fontana, Pēteris Alberts, Kjell S. Sakaríassen et al. · Journal of Thrombosis and Haemostasis Open access	21 Jul 2011	18
25	EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin Kjell S. Sakaríassen, Eti Alessandra Femia, Federico M. Daray et al. · Thrombosis Research Open access	5 Sep 2012	17
26	The internal initiation of translation in bovine viral diarrhea virus RNA depends on the presence of an RNA pseudoknot upstream of the initiation codon Lorin Moes, Manfred Wirth · Virology Journal Open access	2007	15
27	The Natural Diyne-Furan Fatty Acid EV-086 Is an Inhibitor of Fungal Delta-9 Fatty Acid Desaturation with Efficacy in a Model of Skin Dermatophytosis Philipp Knechtle, Melanie Diefenbacher, Katrine B. V. Greve et al. · Antimicrobial Agents and Chemotherapy Open access	5 Nov 2013	13
28	Biosynthesis of angelyl-CoA in Saccharomyces cerevisiae Roberta Callari, David Fischer, Harald Heider et al. · Microbial Cell Factories Open access	12 May 2018	12
29	Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation Fabiana Rollini, Antonio Tello‐Montoliu, Ronakkumar Patel et al. · Journal of Thrombosis and Thrombolysis	13 Aug 2013	12
30	Genomic and functional analyses unveil the response to hyphal wall stress in Candida albicans cells lacking β(1,3)-glucan remodeling Genny Degani, Enrico Ragni, Pedro Botías et al. · BMC Genomics Open access	2 Jul 2016	10
31	Trans-resveratrol reduces visible signs of skin ageing in healthy adult females over 40: an 8-week randomized placebo-controlled trial Amanda Rao, David R. Briskey, Georgia Roche et al. · Frontiers in Aging Open access	19 Dec 2025	9
32	Single ascending oral dose pharmacokinetics and pharmacodynamics study of EV-077: the specific inhibitor of prostanoid- and isoprostane-induced cellular activation Alesia A. Richardson, Kjell S. Sakaríassen, Jean‐Philippe Meyer et al. · European Journal of Clinical Pharmacology	19 Jul 2012	8
33	Increased availability of NADH in metabolically engineered baker’s yeast improves transaminase-oxidoreductase coupled asymmetric whole-cell bioconversion Jan Dines Knudsen, Cecilia Hägglöf, Nora Weber et al. · Microbial Cell Factories Open access	15 Feb 2016	7
34	Pharmacodynamic effects of EV-077: results of an in vitro pilot investigation in healthy volunteers Antonio Tello‐Montoliu, Fabiana Rollini, Bhaloo Desai et al. · Journal of Thrombosis and Thrombolysis	25 Aug 2012	7
35	Identification and characterization of phlorizin transporter from Arabidopsis thaliana and its application for phlorizin production in Saccharomyces cerevisiae Zeinu Mussa Belew, Christoph Crocoll, Iben Møller‐Hansen et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	14 Aug 2020	5
36	Yeast-based assays for screening 11β-HSD1 inhibitors Rosario Vanella, Roberta Callari, Anna A. Weston et al. · Microbial Cell Factories Open access	15 Mar 2016	2
37	Bäckerhefe Saccharomyces cerevisiae als universelle chemische Mikrofabrik Jutta Heim, Thomas Ø Tange, Jens Uwe Klein · BIOspektrum Open access	Jun 2014	1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.